Member Info for FTSEBUYER

https://www.bbc.co.uk/news/health-50507069

I think there are many of the ‘cheesed off’ view. I think the science, potential and brilliance is pretty unquestionable. What is poor is the company’s lack of ability to draw attention to what it’s doing, inefficiency, and seeming inability to extract value from what it has achieved to date.

The money I have put onto Scancell was not a donation to a university facility but an investment in a quoted company. At some point the BOD needs to recognise that shareholders are part owners of the operation and efforts need to be made to create some sort of value before many throw in the towel.

If our BoD can’t think of a better option perhaps Ebay is the way ahead !

Well TF, I’m probably as stale a bull as you can get in SCLP with a 7 +year old holding and impressive losses. We invest for a reason and can only hope that at some point that a return materialises.
Though full of promise and gallons of jam tomorrow it has , for me, not been the finest investment to date.

Is it time to stick SCIB and MODI on Ebay ? With luck there may be a few bids and long suffering shareholders might get something of a return.

Amazing innovative company with cancer busting products.

What value a company with a suite of cancer busting treatments ?
£40m
£400m
£4bn
?
We are now well on the way to knowing if this is what have. Early trial patients still heathy, years later.

Some very serious upside here as positive news comes in.

In for the ride

So, on that basis, as knowledge of the science spreads and results proving SCLP abilities - in humans- become known we should anticipate an unprecedented skyward run. The truth, in all its glory, will (at least start to) become apparent in the coming 18 - 24 months.
I’m in and buckled

As we are with promising but unproven science and a small trial behind us leaving a number of seriously ill patients surviving years beyond expectations - up to £250m

If science is proven not to work at all - down to £0

If science is proven to significantly improve life expectancy in one or two relatively common cancers, at low cost, with few to no unpleasant side effects £1bn ++

If SCLP science platforms proven and multiple cancers ‘treatable’, future cancer treatment changed forever £ A lot.

Just my guess

Can only imagine the share price when Scancell is proven to actually save many lives and defeat multiple cancers.

ha ha. on that tiny clip yes
sadly many many 000s in the red

My last purchase was at 4.2. Seriously not wanting to see that level again

Let’s be happy for a better week.
Let’s be realistic we are still in single figure pennies.
Full of admiration for your limitless enthusiasm.
My first purchase was in the mid 30’s several years ago
Still here. Still a believer
Looking forward to results and returns

Not sure what you’re trying to say. My view remains exactly as it was yesterday.Great deal for the hedgie investor, handy for us to get some cash and support, though somewhat pillaged in the process.

Not sure what you’re trying to say. My view remains exactly as it was yesterday.Great deal for the hedgie investor, handy for us to get some cash and support, though somewhat pillaged in the process.

Relief, I suppose, that a professional investor has belief in the potential of our science to the point of putting up some hard cash. A shame that they are such good negotiators that they managed to get so much for so little.
A lot to look forward to , most of all, hard evidence that Scancell can produce multiple cancer busting products.
Renewed interest in this little company, a massive revaluation of its worth.
Bullish, Bruised and still a Buyer

Hopefully this is - at last - the beginning of a much overdue revaluation

Agreed - good for them
Hopefully our BoD won’t be quite so generous when big pharma come knocking

Great - very cheap- purchase by Vulpes. Good for them.

Moon - perhaps I’ve missed something. Vulpes is a hedge fund (with a decent position in avocados) 5p is close to our all time low. We have been diluted at that level in favour of a non strategic partnership.

Though good news for Scancell to have a few more quid in the bank to burn up in the development of these potentially life changing products. Seems a shame to me that our board sees fit to sell a big chunk of our company close to the all time lows. What a deal this could be for the crafty hedge fund, all they need is for a little rally back to where we were a few weeks ago and they can sell out for a healthy profit. No strategic advantage in tying up with this lot. Great pity that they didn’t get sent into the market to pick up their position like the rest of us .

I know we are trading at 5 pence with a market cap of about £20m
If SCIB1, SCIB2 and the Modi group all perform as early indications imply, Scancell will be the proprietor of a complete family of cancer busting, life enhancing and extending ‘super treatments’. Perhaps sounds ‘pie in the sky’ today but it really could have a value of at least £1bn when all that starts to fall into place. That’s a share price of 1000 pence.
Every chance as data from the trials starts flooding in we’ll get gobbled up by big pharma before we get to that point.